The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session will provide health centers with a general update on the 340B drug pricing program that includes the topics of litigation status, manufacturer restrictions, and any anticipated regulatory challenges related to the program. Given the current status of the program, attendees will be given advocacy tools to employ to help defend the program at the state and federal levels.
Learning Objectives
Understand the status of pending 340B litigation.
Understand manufacturer restriction updates on the 340B program.
Identify key issues plaguing the 340B program and what the future outlook is for the program.
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.